Trial intelligence / Profile preview

Remimazolam tosilate + esketamine vs propofol + remifentanil for anesthesia in ureteroscopic lithotripsy

ChiCTR2600130927Phase 4Recruiting

Sponsor
Linquan County People's Hospital
Start
May 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remimazolam and esketamine in ureterolithiasis (2 arms), sponsored by Linquan County People's Hospital. Primary endpoints: Vital signs and Patient awakening quality. Started May 2025; status: recruiting.

02

Drugs

remimazolamesketamine
03

Conditions

ureterolithiasis

Beyond the preview

Go deeper on ChiCTR2600130927.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2600130927.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call